Garbe C - Search Results

1

Cutaneous melanoma in the elderly: epidemiology, prognosis and treatment.

Lasithiotakis KG, Petrakis IE, Garbe C. Lasithiotakis KG, et al. Among authors: garbe c. Melanoma Res. 2010 Jun;20(3):163-70. doi: 10.1097/CMR.0b013e328335a8dd. Melanoma Res. 2010. PMID: 20375923 Review.

2

The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.

Lasithiotakis KG, Leiter U, Gorkievicz R, Eigentler T, Breuninger H, Metzler G, Strobel W, Garbe C. Lasithiotakis KG, et al. Among authors: garbe c. Cancer. 2006 Sep 15;107(6):1331-9. doi: 10.1002/cncr.22126. Cancer. 2006. PMID: 16909413 Free article.

3

Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed?

Lasithiotakis KG, Leiter U, Eigentler T, Breuninger H, Metzler G, Meier F, Garbe C. Lasithiotakis KG, et al. Among authors: garbe c. Cancer. 2007 Mar 15;109(6):1174-82. doi: 10.1002/cncr.22511. Cancer. 2007. PMID: 17265520 Free article.

4

Diagnosis and treatment of cutaneous melanoma: state of the art 2006.

Garbe C, Eigentler TK. Garbe C, et al. Melanoma Res. 2007 Apr;17(2):117-27. doi: 10.1097/CMR.0b013e328042bb36. Melanoma Res. 2007. PMID: 17496787 Review.

5

Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma.

Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R. Garbe C, et al. Melanoma Res. 2008 Feb;18(1):61-7. doi: 10.1097/CMR.0b013e3282f0c893. Melanoma Res. 2008. PMID: 18227710

6

Age and gender are significant independent predictors of survival in primary cutaneous melanoma.

Lasithiotakis K, Leiter U, Meier F, Eigentler T, Metzler G, Moehrle M, Breuninger H, Garbe C. Lasithiotakis K, et al. Among authors: garbe c. Cancer. 2008 Apr 15;112(8):1795-804. doi: 10.1002/cncr.23359. Cancer. 2008. PMID: 18306371 Free article.

7

Combined inhibition of MAPK and mTOR signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells.

Lasithiotakis KG, Sinnberg TW, Schittek B, Flaherty KT, Kulms D, Maczey E, Garbe C, Meier FE. Lasithiotakis KG, et al. Among authors: garbe c. J Invest Dermatol. 2008 Aug;128(8):2013-23. doi: 10.1038/jid.2008.44. Epub 2008 Mar 6. J Invest Dermatol. 2008. PMID: 18323781 Free article.

8

Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.

Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R. Garbe C, et al. Melanoma Res. 2008 Apr;18(2):152-60. doi: 10.1097/CMR.0b013e3282f702bf. Melanoma Res. 2008. PMID: 18337653

9

Inhibition of PI3K-AKT-mTOR signaling sensitizes melanoma cells to cisplatin and temozolomide.

Sinnberg T, Lasithiotakis K, Niessner H, Schittek B, Flaherty KT, Kulms D, Maczey E, Campos M, Gogel J, Garbe C, Meier F. Sinnberg T, et al. Among authors: garbe c. J Invest Dermatol. 2009 Jun;129(6):1500-15. doi: 10.1038/jid.2008.379. Epub 2008 Dec 11. J Invest Dermatol. 2009. PMID: 19078992 Free article.

10

Costs of the detection of metastases and follow-up examinations in cutaneous melanoma.

Leiter U, Marghoob AA, Lasithiotakis K, Eigentler TK, Meier F, Meisner C, Garbe C. Leiter U, et al. Among authors: garbe c. Melanoma Res. 2009 Feb;19(1):50-7. doi: 10.1097/CMR.0b013e32831bc41c. Melanoma Res. 2009. PMID: 19430406

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

802 results

Search Page

Filters